Gene dosage PCR and fluorescence in situ hybridization reveal low frequency of egfr amplifications despite protein overexpression in invasive breast carcinoma

作者: Christian Kersting , Nicola Tidow , Hartmut Schmidt , Cornelia Liedtke , Joerg Neumann

DOI: 10.1038/LABINVEST.3700077

关键词:

摘要: The aim of this study was to assess the frequency egfr whole gene and CA intron repeat amplification in invasive breast cancer as a mechanism for epidermal growth factor receptor (EGFR) protein overexpression. By means tissue microarrays, overexpression were assessed 222 cases by immunohistochemistry FISH, respectively. First Taqman RT-PCR. With FISH RT-PCR, 4.7 6.3% showed first amplification, Amplification dosage varied between two- four-fold immunohistochemistry, 17.3% EGFR There low correlation different methods. In all, 2.9% both 90.3% negative both. Nearly 20% with immunohistochemical only 2.2% that on such amplification. 13% 1.6% Of overexpression, 4 (25%) either or conclusion, amplifications are rare explain about 12.5% cases. is another important explaining 18.7% However, since 75% lack these amplifications, other expression regulating mechanisms must be considered.

参考文章(26)
ANTJE ROETGER, BURKHARD BRANDT, ANGELIKA BARNEKOW, Competitive-differential polymerase chain reaction for gene dosage estimation of erbB-1 (egfr), erbB-2, and erbB-3 oncogenes. DNA and Cell Biology. ,vol. 16, pp. 443- 448 ,(1997) , 10.1089/DNA.1997.16.443
Janet E Dancey, Boris Freidlin, Targeting epidermal growth factor receptor--are we missing the mark? The Lancet. ,vol. 362, pp. 62- 64 ,(2003) , 10.1016/S0140-6736(03)13810-X
STEPHEN B. HUNTER, KAREN ABBOTT, VIJAY A. VARMA, JEFFREY J. OLSON, DAVID W. BARNETT, C. David James, Reliability of Differential PCR for the Detection of EGFR and MDM2 Gene Amplification in DNA Extracted from FFPE Glioma Tissue Journal of Neuropathology and Experimental Neurology. ,vol. 54, pp. 57- 64 ,(1995) , 10.1097/00005072-199501000-00007
J. Richard, C. Sainsbury, GeoffreyK. Needham, JohnR. Farndon, ArchieJ. Malcolm, AdrianL. Harris, EPIDERMAL-GROWTH-FACTOR RECEPTOR STATUS AS PREDICTOR OF EARLY RECURRENCE OF AND DEATH FROM BREAST CANCER The Lancet. ,vol. 1, pp. 1398- 1402 ,(1987) , 10.1016/S0140-6736(87)90593-9
J Packeisen, E Korsching, H Herbst, W Boecker, H Buerger, Demystified...tissue microarray technology. Molecular pathology : MP. ,vol. 56, pp. 198- 204 ,(2003) , 10.1136/MP.56.4.198
Frank Gebhardt, Kurt S. Zänker, Burkhard Brandt, Modulation of epidermal growth factor receptor gene transcription by a polymorphic dinucleotide repeat in intron 1. Journal of Biological Chemistry. ,vol. 274, pp. 13176- 13180 ,(1999) , 10.1074/JBC.274.19.13176
Serban Costa, Hans Stamm, Alfonso Almendral, Hans Ludwig, Rudolf Wyss, Doriano Fabbro, Andreas Ernst, Atsuro Takahashi, Urs Eppenberger, Predictive value of EGF receptor in breast cancer. The Lancet. ,vol. 332, pp. 1258- ,(1988) , 10.1016/S0140-6736(88)90856-2
Juha Kononen, Lukas Bubendorf, Anne Kallionimeni, Maarit Bärlund, Peter Schraml, Stephen Leighton, Joachim Torhorst, Michael J Mihatsch, Guido Sauter, Olli-P. Kallionimeni, Tissue microarrays for high-throughput molecular profiling of tumor specimens Nature Medicine. ,vol. 4, pp. 844- 847 ,(1998) , 10.1038/NM0798-844
Caroline J Witton, Jonathan R Reeves, James J Going, Timothy G Cooke, John MS Bartlett, Expression of the HER1–4 family of receptor tyrosine kinases in breast cancer The Journal of Pathology. ,vol. 200, pp. 290- 297 ,(2003) , 10.1002/PATH.1370